← Human Trials & Peer-Reviewed Studies
Vitamin D status of inmates: the experience of penitentiaries prisons in the province of Salerno in Southern Italy.
Plain-language guide to PMID 36373454 (2022): observational study of Vitamin D, K2, Magnesium and Zinc.
Key Facts
- PMID
- 36373454
- Journal
- La Clinica terapeutica
- Year
- 2022
- Study type
- Observational Study
- Authors
- De Leo M et al. (10 authors)
- DOI
- 10.7417/CT.2022.2481
What This Study Did, in Plain Language
What Was Tested
Researchers studied Vitamin D, K2, Magnesium and Zinc in this observational study publication.
To investigate vitamin D status and its determinants in a cohort of prisoners.
Why It Was Studied
Prisoners are at risk of developing vitamin D deficiency due to their lacking exposure to sunlight.
So far, there are no published studies evaluating blood levels of vitamin D in relation to the health status of inmates and the quality of the Italian prison system.
Who Took Part
By PubMed's age tags, the people studied were adults and middle-aged adults, both men and women.
How the Study Was Run
One hundred and seventy-two (172) pri-son inmates (males, n=159, age 47± 11.3 years; females, n=13, age 43.91±12.18 years) of three penitentiaries in the province of Salerno.
Vitamin D deficiency, insufficiency and sufficiency were respectively defined as a 25(OH)D level <20 ng/mL; from 20 to 30 ng/mL, >30 ng/mL.
What Was Measured
So far, there are no published studies evaluating blood levels of vitamin D in relation to the health status of inmates and the quality of the Italian prison system.
Topics PubMed links to this paper include Prisons, Vitamin D, Italy, Vitamin D Deficiency, Prisoners, Vitamins and Prevalence.
The authors tagged it with the keywords inmates blood deficiency and right to health.
What This Means in Plain Language
This is an observational study of Vitamin D, K2, Magnesium and Zinc.
Its findings take up roughly 4 sentences of the abstract and are left out here on purpose; the source paper is the place to read them.
The publication is from 2022 (La Clinica terapeutica), a journal based in Italy.
More context: the Vitamin D, K2, Magnesium and Zinc compound page, all human trials.
Our Notes on the Compound
Vitamin D, K2, Magnesium and Zinc: Magnesium is described as required for AMPK to function.
Related Pages
Source: PubMed record. This explanation is written by PeptideWhiz from the public record. For research and education only. Not medical advice; no dosing information is given.